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Abstract
Early development in humans is characterised by low and variable embryonic viability, reflected in low fecundity and high
rates of miscarriage, relative to other mammals. Data from assisted reproduction programmes provides additional evidence
that this is largely mediated at the level of embryonic competence and is highly heterogeneous among embryos.
Understanding the basis of this heterogeneity has important implications in a number of areas including: the regulation of
early human development, disorders of pregnancy, assisted reproduction programmes, the long term health of children
which may be programmed in early development, and the molecular basis of pluripotency in human stem cell populations.
We have therefore investigated global gene expression profiles using polyAPCR amplification and microarray technology
applied to individual human oocytes and 4-cell and blastocyst stage embryos. In order to explore the basis of any variability
in detail, each developmental stage is replicated in triplicate. Our data show that although transcript profiles are highly
stage-specific, within each stage they are relatively variable. We describe expression of a number of gene families and
pathways including apoptosis, cell cycle and amino acid metabolism, which are variably expressed and may be reflective of
embryonic developmental competence. Overall, our data suggest that heterogeneity in human embryo developmental
competence is reflected in global transcript profiles, and that the vast majority of existing human embryo gene expression
data based on pooled oocytes and embryos need to be reinterpreted.
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Introduction
Development of the human embryo begins at fertilisation with
fusion and reprogramming of the gamete pronuclei, followed by a
series of cleavage stages and activation of the embryonic genome
[1,2,3]. After embryonic genome activation (EGA) and cleavage
compaction occurs, the blastocyst forms giving rise to the first
differentiated tissues, the trophectoderm and inner cell mass [4].
Although early human development shares many features with
other species, there are also some notable differences particularly
in the timing of embryonic genome activation (EGA) which has
been shown to occur at the two-cell stage in the mouse, four-cell
stage in the pig and eight-to sixteen- cell stage in the sheep, cow
and rabbit (for a comprehensive review see Telford et al [5]. In the
human, EGA was thought to occur at the four-cell stage [1,4,6],
however, Vassena et al, [3] has shown EGA may occur in the
human embryo as early as the two-cell stage. Our current
understanding of this phase of development is limited, and little is
known about the molecular mechanisms that control the
developmental programme which occurs following fertilisation.
This lack of knowledge is a major concern as there is increasing
evidence that the genetic and epigenetic blueprint for development
is laid down at the preimplantation stage. In this period, parental
genomes are reconfigured and the new embryonic genome is
activated, methylation imprints are re-established, and the earliest
stages of foetal development occur. Data from animal models and
human assisted reproduction technologies (ART) has established
beyond doubt that this sensitive period is highly vulnerable to
perturbation [7]. In ART, the lack of basic understanding of
regulators of human embryo viability and health is hampering
efforts to select and transfer a single embryo, reducing success
rates, increasing risk to offspring, and continuing to expose women
to the increased risk of multiple pregnancy from multiple embryo
transfer. The inability to characterise normal human embryonic
development also has implications for the safety and efficacy of
human embryonic stem cell (hESC) technologies, especially with
the recent development of these towards clinical therapies. Major
aspects of health and disease in adult life are now also widely
recognised to originate as early as the preimplantation embryonic
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stages, including diseases arising from aberrations in fetal
programming [8] and aberrant genomic imprinting [9–12].
It is therefore essential that we begin to unravel the molecular
basis of early human development. Studies to date have been
hindered by the small size of the mammalian preimplantation
embryo and in the case of the human, the lack of embryos
available for research for ethical reasons. Global transcript
profiling using microarrays has been widely used to provide
insight into animal oocytes and their transition into early embryos
[13–15] and this approach has also been applied to human
embryos [16–22]. These studies have provided valuable baseline
data, but have analysed pooled oocytes and embryos. Very
recently, technological advances have allowed microarray tech-
nology to be applied to individual oocytes and embryos. Vassena
et al. [3] have used single human oocyte and embryo samples to
demonstrate that embryonic genome activation (EGA) is initiated
in waves of transcriptional activation in early preimplantation
development.
However, the defining feature of early human development is
heterogeneity. In contrast to animal models, human embryos vary
considerably in their developmental competence, as established by
data from normal reproduction (e.g. miscarriage rates and
pregnancy complications) and human ART programmes. This
heterogeneity is also reflected in the limited number of molecular
studies available to date on individual embryos at a range of stages
of development [23–25]. Therefore any attempts to understand
the molecular basis of human development need to analyse
heterogeneity at the single embryo level.
The aim of this study was therefore to investigate the global
gene expression profile at three key developmental stages spanning
human preimplantation embryo development; the metaphase II
oocyte; followed by the 4-cell stage at which point EGA has
occurred in human preimplantation development, and then the
blastocyst, the stage immediately prior to implantation. We have
employed polyAPCR amplification and microarray technology to
investigate the wide ranging expression of genes during preim-
plantation development at the single embryo level. Our data
suggest that the heterogeneity in human embryo development is
reflected in global transcriptional profiles, and that existing human
embryo microarray data based on pooled oocytes and embryos
need to be reinterpreted.
Results
We have utilised and further developed PolyAPCR amplifica-
tion technology to generate sufficient cDNA from individual
human oocytes and preimplantation embryos [26 27] to allow
global transcriptome profiling using cDNA microarrays for the key
developmental stages spanning preimplantation development. The
PolyAcDNA was generated from single human oocytes and
embryos surplus to IVF requirements and hybridised to Affymetrix
U133 microarray gene chips to assess the expression of 47 000
transcripts [28]. The microarray data were validated by addition-
ally using quantitative-PCR to confirm expression of a number of
key genes. TP53, GAS5, POU5F1, NANOG, ZFP42, CDX2 and
EIF1AX were called present in all blastocyst samples and exhibited
variable expression in four-cell embryos. Expression of these genes
was confirmed by qPCR (see [27] for further detail). Oocytes also
showed variable expression of these genes which was also
confirmed by qPCR (unpublished data).
We chose to analyse oocytes, 4-cell embryos and blastocysts in
order to gauge the extent of expression of maternal transcripts,
their degradation by the 4-cell stage, and expression of new
transcripts following EGA. We analysed 3 oocytes/embryos from
different donors, in order to achieve the goals of examining
heterogeneity at a level of detail not possible with large sample sets.
For ethical reasons the oocytes were only available 24 hours after
insemination, hence their gene expression patterns could be
slightly different to fresh oocytes obtained on the day of egg
collection. However we have shown previously that the two
sources of oocytes yield comparable embryos and human
embryonic stem cell lines with similar gene expression patterns
[29,30].
Comparison between individual human oocytes, 4-cell embryos
and blastocysts shows that within each stage, global gene
expression is broadly reproducible, as indicated by transcripts
expressed in common between two samples at the same stage,
compared to those expressed uniquely (Figure 1). A large number
of transcripts were expressed in oocytes and blastocysts, with very
few expressed at the 4-cell stage.
Our data also reveal significant variation amongst individual
oocytes and embryos. Figure 1 shows increased variation in
transcript expression in oocyte #3, 4-cell embryo #1 and
blastocyst #3. Oocyte 1 and 2 expressed similar transcription
profiles, with oocyte 3 expressing fewer unique transcripts than the
others (Figure 1). Four-cell embryos 2 and 3 displayed less scatter
when compared to each other, but each sample expressed largely
unique transcripts with very few expressed in common (Figure 1).
Blastocysts 1 and 2 showed a similar expression profile but
blastocyst 3 showed a more differential expression profile with
increased scatter due to the expression of unique transcripts in this
sample or different levels of expression of common transcripts
between this sample and blastocyst 1 or blastocyst 2 (Figure 1).
Global Gene Expression Profiles of Individual Oocytes
and Blastocysts
The scatterplot data in Figure 1 are presented as Venn diagrams
in Figure 2. In the oocyte (Figure 2A), approximately 16,000
different transcripts were expressed across the three samples (i.e. in
at least one), with 4615 of these (30% of the total) expressed in all 3
oocytes. Oocytes 1 and 2 each expressed over 11,000 transcripts
whereas oocyte 3 expressed over 7000 transcripts. Oocytes 1 and 2
each exclusively expressed approximately 3000 transcripts,
whereas oocyte 3 exclusively expressed only 1447 transcripts
(Figure 2A). Oocytes 1 and 2 shared many more transcripts in
common than either did with oocyte 3.
In the blastocyst (Figure 2B), again approximately 16,000
different transcripts were expressed across the three embryos, with
3343 of these (20% of the total) expressed in all three blastocysts.
Individual blastocysts expressed 9655, 9764 and 8818 transcripts,
respectively, with a similar degree of overlap to that seen in the
oocyte samples. Blastocysts 1 and 2 shared 1727 transcripts in
common (Figure 2B). Blastocyst 3 expressed 2112 unique
transcripts, but shared 2220 common transcripts with blastocyst
1, more than those in common between blastocysts 1 and 2 or the
1143 shared by blastocysts 2 and 3 (Figure 2B). This analysis
allows a quantitative estimate of the variability in extent of EGA in
individual embryos. Blastocysts 1 and 2 express very similar
numbers of genes, at 9655 and 9764 respectively (Figure 2B), but
blastocyst 3 expresses considerably fewer, at 8818 genes. Assuming
that the baseline level of gene expression at the 4-cell stage is very
low, this means the EGA in blastocyst 3 is occurring at about 90%
of the efficiency of that in blastocysts 1 and 2.
In order to further compare the heterogeneity in expression
profiles suggested in Figures 1 and 2, and examine the similarities
between same stage samples and qualitative difference between
oocytes and blastocysts, we performed a heatmap cluster analysis
of the three individual oocyte and blastocyst samples (Figure 3). All
Heterogeneity in Single Human Oocytes and Embryos
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three oocytes clustered together and separately to the three
blastocysts, as predicted. Oocytes 1 and 2 were clearly more
similar to each other than to oocyte 3, and blastocysts 1 and 2
more similar to each other than to blastocyst 3, confirming the
relationships observed in Figure 1.
The Molecular Signature of Development From Oocyte
To Four-cell Embryo and Blastocyst
In order to obtain a quantitative estimate of expression of
maternal transcripts, their removal by the 4-cell stage, and
expression of new transcripts following EGA, we compared all
three stages of development (Figure 4). We analysed genes
expressed in all three individual oocytes or embryos at each stage
(3/3), in order to establish ‘‘essential’’ baseline gene expression
before and after EGA (Figure 4A). We then analysed gene
expression represented in at least 2 replicates out of 3 samples (2/
3), at each stage (Figure 4B). This generates a much more
‘‘permissive’’ dataset of gene expression, since transcripts are not
excluded from the analysis because they are not called Present in
one replicate sample. This also highlights the strength of an
individual embryo analysis, as the difference between expression in
at least 2/3 samples relative to 3/3 samples might identify the
expression of genes important in conferring embryonic compe-
tence. We have not analysed genes expressed in only 1/3 samples,
as it is unlikely that this would be representative of development
and is not a significant advance on the previous approach of
analysing data from pooled embryos.
Four-cell embryos expressed only 59 transcripts in all three
embryos (Figure 4A). These were mainly ribosomal transcripts.
However, the 4 cell embryo exclusively expressed Collagen and
calcium binding domains EGF1 (CCBE1), Maternally expressed 3
(MEG3), the cAMP regulator, Phosphodiesterase 6B (PDE6B) and
Natural killer tumour recognition sequence (NKTR). Two other
transcripts exclusive to the 4-cell embryo were identified (accession
numbers AK023918 and AI133727), but have not yet been
characterised. In at least 2/3 4-cell embryos, a total of 338
transcripts were expressed, with 25 transcripts coding for mainly
ribosomal proteins exclusive to this stage (Figure 4B). These
represent the few messages which are transcribed very early, and
transiently, from the embryonic genome, and are removed from
transcription by the blastocyst stage. Of the 48 transcripts shared
between all oocytes and all 4-cell embryos, only 1 transcript was
exclusive to both oocytes and 4-cell embryos (Figure 4A) and this
transcript is currently uncharacterised (accession number
AK024819). In at least 2/3 oocytes and 4-cell embryos, 303 were
Figure 1. Scattergraph plots comparing gene expression of individual human oocytes, 4-cell embryos and blastocysts. Each of three
individual samples at each stage is compared to each of the others. Red dots represent transcripts called Present in both samples, yellow dots
represent transcripts absent in both samples and blue dots represent transcripts Present in one sample and not the other. The innermost oblique
lines represent 2-fold differentially expressed transcripts. Additional pairs of lines represent transcripts expressed at 5, 10- and 20-fold, respectively. As
expected, fewer genes were called Present at the 4-cell stage which reflects the degradation of polyA containing maternal transcripts by the 4-cell
stage during EGA.
doi:10.1371/journal.pone.0064192.g001
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common but only 30 of these were shared exclusively between
oocytes and 4-cell embryos (Figure 4B). These transcripts which
code for genes such as RAS-related –GTP binding C (RRAGC),
Sorting Nexin 24 (SNX24), Arginine/serine-rich_coiled-coil_2
(RSRC2) and Dishevelled associated activator of morphogenesis
1 (DAAM1) represent maternal message expressed by the oocyte
but removed by the onset of EGA. Solute_carrier_family_11
member 1 (SLC11A1), UBA and WWE domains containing
Figure 2. Venn diagrams showing the number of expressed transcripts unique and common to individual oocyte and blastocyst
samples. A Individual oocytes expressed a number of transcripts that were unique to each one, relative to the remaining oocytes. Some transcripts
were common between two individual samples and 4615 transcripts were common to 3/3 oocytes. Note that oocytes 1 and 2 shared more common
transcripts with each other than with oocyte 3. These transcripts may not be exclusive to oocytes and may also be expressed in 1, 2 or all 4-cell
embryo and blastocyst samples. B Individual blastocysts expressed a number of transcripts unique to each one. Some transcripts were common
between two individual blastocysts and 3343 transcripts were common to all three samples. These transcripts may not be exclusive to the blastocyst
stage and may also be expressed in 1, 2 or all oocyte and 4-cell embryo samples.
doi:10.1371/journal.pone.0064192.g002
Figure 3. Heatmap cluster analysis of individual oocyte and blastocyst gene expression profiles. Hierarchical clustering was used to
compare the gene expression profiles of individual oocytes and blastocysts, with highly expressed genes shown in red, weakly expressed in green.
Oocytes show clearly distinct profiles from blastocysts, with oocytes 1 and 2 more similar to each other than to oocyte 3, and blastocyst 1 and 2 more
similar to each other than to blastocyst 3. 4-cell embryos were omitted from this analysis based on the low abundance of expressed transcripts.
doi:10.1371/journal.pone.0064192.g003
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protein 1 (HUWE1), an alternate transcript coding for NKTR and
three other uncharacterised transcripts (accession numbers
AA639753, AU146391 and R43103) were common to all 4-cell
embryos and all blastocysts (Figure 4A). Sialophorin (SPN),
Troponin T type 3 (TNNT3), Syndecan 4 (SDC4), Adam
Metallopeptidase domain 33 (ADAM33), Connector enhancer of
kinase suppressor of RAS-2 (CNKSR2) and 5 other uncharacterised
transcripts were common to at least 2/3 4-cell and blastocyst
embryos (Figure 4B). Transcripts shared between 4-cell embryos
and blastocysts but not oocytes, represent message that is newly
expressed by the embryonic genome following EGA and persists to
the blastocyst stage. All oocytes, 4-cell embryos and blastocysts
shared 47 common transcripts (Figure 4A) whereas in at least 2/3
oocytes and embryos, 273 transcripts were common to all stages
(Figure 3B). These latter transcripts represent maternal messages
which persist at least to the 4-cell stage, and continue to persist to
the blastocyst stage, or are re-expressed from the embryonic
genome.
Pathway Analysis of Single Human Oocytes and
Blastocysts
We analysed components of 10 different pathways that were
highly represented (P,0.05; q,0.22) in our individual human
oocyte and blastocyst sample sets. We assessed transcripts that
were significantly and uniquely represented in oocytes and
blastocysts, and also those genes that were common to both
oocytes and blastocysts (Table 1). In order to understand the
molecular basis of oocyte and blastocyst heterogeneity and possibly
developmental competence, we also assessed the differential
expression of transcripts that were significantly represented in
the two similar oocytes (1 and 2) relative to oocyte 3, and also in
the two similar blastocysts (1 and 2) relative to blastocyst 3
(Table 2).
Expression of Components Involved in Apoptosis, TP53
Signalling, Cell Cycle, and Progesterone Mediated Oocyte
Maturation
Components of apoptosis, cell cycle and progesterone mediated
oocyte maturation pathways were highly represented in the
oocytes and blastocysts (P,0.05; q#0.22) (Table 1). Pathway
analysis revealed that some of these components were unique to all
oocyte samples and included cytokine induced inhibitor of
apoptosis 1 (CIAPIN1), inhibitor of kappa light chain gene
enhancer in B cells, kinase of beta (IKBKB), CD82, cell division
cycle 25A (CDC25A) origin recognition complex 5(ORC5) and
cytoplasmic polyadenylation element-binding protein 2 (CPEB2).
Relative to the oocyte, fewer transcripts were uniquely expressed
in all blastocyst samples (P,0.05; q#0.22) (Table 1). Of these
genes, SMC1A and FBXO5 whose expression has not previously
been reported in blastocysts were significantly represented. There
were a number of significantly expressed genes (P,0.05; q#0.22)
involved in these pathways that were common to all oocyte and
blastocyst samples. These genes included cytochrome C somatic
(CYCS), checkpoint 1 (CHEK1), ribonucleotide reductase M2
(RRM2), RAD21, TTK, cell division cycle 20(CDC20), histone
deacetylase 2 (HDAC2), minichromosome maintenance 6
(MCM6), proliferating cell nuclear antigen (PCNA), tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein
beta (YWHAB) and theta (YWHAQ).
Genes expressed in oocytes 1 and 2 were significantly
represented (P,0.05; q#0.22) in the cell cycle and progesterone
mediated oocyte maturation and meiosis and include anaphase
promoting components S-phase associated kinase 2 (SKP2),
(ANAPC)-7, -11 and -13, cell cycle division cycle 16 (CDC16),
Fizzy related protein 1 (FZR1) and transcription factor DP1
(TFDP1). Oocyte 3 uniquely and significantly (P,0.05; q#0.22)
Figure 4. Venn diagrams showing the number of expressed transcripts unique and common to the different stages of
development. A. A number of transcripts were uniquely expressed at a single stage: in 3/3 oocyte samples, all three 4-cell embryos and all three
blastocysts. However, some transcripts were common between two different stages of development whereas some transcripts were common to all
stages of development. B A number of transcripts were expressed in at least 2/3 oocytes, four-cell and blastocyst embryos. 273 transcripts were
common to all stages of oocyte and embryo development. Over 3880 transcripts were expressed in at least 2/3 oocyte and blastocyst samples and
not expressed at the four-cell stage. 30 transcripts were common to at least 2/3 oocyte and four-cell embryos and were not expressed in blastocysts.
Only 4 more transcripts were shared exclusively between at least 2/3 four-cell embryos and blastocysts when compared to all four-cell and blastocyst
embryos. These transcripts represent message that is transcribed early from the embryonic genome.
doi:10.1371/journal.pone.0064192.g004
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expressed the proapoptotic factors BID, caspase-9 (CASP9) and
CDC23.
Genes expressed in blastocysts 1 and 2 included cyclin
dependant kinase 2 (CDK2, the MAPK-regulated component
PPM1D, sestrin-2 (SESN2) and TFDP2 (Table 2). The proapopto-
tic genes CASP9, tumour necrosis factor receptor superfamily
member (TNFSFR)-10A and -10B, were also highly represented
(P,0.05; q#0.22) (Table 2). Blastocyst 3 expressed relatively fewer
components that were representative of these pathways (Table 2)
but genes included growth arrest and DNA-damage-inducible 45,
Table 1. Pathways significantly represented in all oocytes and blastocysts.
Pathway Oocyte Specific Blastocyst Specific Oocyte and Blastocyst
Apoptosis CIAPIN1 (NM_020313) CYCS (BC005299)
IKBKB (AU153366) PRKAR2A (AK026351)
PRKAR2A (BF246917)
TP53 signalling CD82 (NM_002231) PERP (AJ251830) CHEK1(NM_001274)
CYCS (BC005299)
RRM2 (BC001886)
Cell Cycle CDC25A (AY137580) SMC1A (BC046147) CHEK1 (NM_001274)
ORC5L (NM_002553) RAD21 (NM_006265)
TTK (NM_003318)
CDC20 (NM_001255)
HDAC2 (NM_001527)
MCM6 (NM_005915)
PCNA (NM_002592)
YWHAB (BF246499)
YWHAQ (NM_006826)
Progesterone mediated oocyte maturation
and oocyte meiosis
CDC25A (AY137580) FBXO5 (NM_012177) CDC20 (NM_001255)
CPEB2 (BE646645) SMC1A (D80000) YWHAB (BF246499)
CALM1 (AI653730) YWHAQ (NM_006826)
TGFb Signalling SMURF2 (AY014180) SMAD5 (BF526175)
SP1 (BG431266)
ACVR2A (AI149508)
ACVR2B (NM_001106)
FST (NM_013409)
Extracellular matrix and focal adhesion FN1 (BC005858) ITGB3 (AI151479) GRB2 (AF246238)
CIAPIN1 (NM_020313) HMMR (U29343) ITGB1 (BG500301)
PRKCG (AW027690) LAMA5 (BC003355)
LAMB1 (NM_002291)
Purine/Pyrimidine Metabolism AMPD3 (NM_000480) CTPS1 (AK025654) APRT (AA927724)
FHIT (NM_002012) IMPDH1 (NM_000883) DGUOK (BC001121)
PDE8B (AK023913) PFAS (AL044326) GMPS (NM_003875)
POLR2E (NM_002695) POLR1B (BC004882)
POLR3G (NM_006467) POLR2L (BC005903)
PRIM2 (NM_000947)
RRM2B (AB036063)
Valine, Leucine and Isoleucine Biosynthesis BCAT1 (NM_005504)
LARS (D84223)
PDHB (M34055)
Pyruvate metabolism LDHAL6A (NM_144972) DLAT (BF978872) PDHA1 (AW057819)
ACYP1 (NM_001107) PDHB (M34055) GALM (AI769923)
Glycolysis/Gluconeogenesis LDHAL6A (NM_144972) PDHB (M34055) LDHA (NM_005566)
DLAT (BF978872) PDHA1 (AW057819)
Listed entries represent transcripts and their respective NCBI accession numbers that were significantly expressed (P,0.05; q#0.22) in the appropriate sample(s). ‘‘-‘‘
denotes no significantly expressed components were detected in the pathway.
doi:10.1371/journal.pone.0064192.t001
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gamma (GADD45G), pituitary tumour transforming gene 1
(PTTG1) and protein kinase DNA activated catalytic subunit
(PRKDC).
Expression of Components Involved in the TGFb
Superfamily Signalling Pathway
A number of components in the TGFb superfamily signalling
cascade were significantly (P,0.05; q#0.22) detected (Table 1).
Smad specific E3 ubiquitin protein ligase 2 (SMURF2), the
transcription factor SP1, activin A receptors type IIA and B
(ACVR2A, -B) and the activin inhibitor follistatin (FST) were
uniquely expressed in all oocyte samples. SMAD5 was common to
all oocyte and blastocyst samples (Table 1). There were no
significantly (P,0.05; q#0.22) expressed TGFb signalling path-
way transcripts that were unique to all blastocyst samples.
Oocytes 1 and 2 expressed the transcription factor TFDP1
which has been implicated in linking TGFb receptor activity to c-
myc repression by forming a complex with smad3, E2F4/5 and
p107 which translocates to the nucleus, binds to smad4 and
represses c-myc expression [31]. Mitogen activated protein kinase
1 MAPK1, a key regulator of the MAPK signal transduction
cascade as well as the TGFb cascade is also significantly expressed
by oocytes 1 and 2 (Table 2). Blastocysts 1 and 2 significantly
expressed (P,0.05; q#0.22) three members of the TGFb
signalling pathway, SMAD1, SMAD6 and SMURF2 (Table 2). In
contrast, oocyte 3 and blastocyst 3 did not significantly express any
TGFb superfamily signalling molecules.
Expression of Components Involved in Extracellular
Matrix and Focal Adhesions
A number of cell adhesion molecules were significantly
represented (P,0.05; q#0.22) in this study. Fibronectin 1 (FN1)
was exclusively expressed in all oocytes. CIAPIN1, whose
expression is dependent on embryo-related growth factors such
as stem cell factor (SCF) and IL-13 32 (Shibayama et al., 2004).
Protein kinase C gamma (PRKCG), previously detected in mature
human oocytes [33], was also uniquely expressed in oocytes
(Table 1). Integrin b3 (ITGB3) is an adhesion molecules with a
known role in preimplantation and peri-implantation development
[34], and hyaluronan mediated mobility receptor (HMMR), which
has been postulated to have a role in the maintenance of ESC
pluripotency [35] were significantly expressed in all blastocyst
samples (Table 1). Phosphatidylinositol 3-kinase regulatory subunit
2 (PIK3R2), integrin b1 (ITGB1), laminin a5 (LAMA5) and
Laminin b1 (LAMB1) involved in cell –extracellular matrix
interaction and signalling were significantly represented (P,0.05;
q#0.22) and common to all oocyte and blastocyst samples
(Table 1).
Several transcripts involved in the extracellular and focal
adhesion signalling cascades were significantly expressed in
oocytes 1 and 2 relative to their third counterpart. Phosphatidy-
linositol 3-kinase class 2 b (PIK3C2B), which has been previously
shown to regulate cell mobility by reorganising the actin
cytoskeleton [36], RAS-related protein 1A (RAP1A), was detected
in human oocytes [37] and is postulated to play a role in regulating
normal morphogenesis [38], SHC transforming protein 2 (SHC2),
laminin a3 (LAMA3) and the previously mentioned MAPK1 and
TFDP1 were highly represented in oocytes 1 and 2 (Table 2).
Oocyte 3 did not significantly express transcripts that were highly
represented in these pathways (Table 2). Blastocysts 1 and 2 also
expressed LAMA3 together with SHC1, collagen type III a1
(COL3A1), P21-activated kinase 2 (PAK2), protein phosphatase 1b
(PPP1CB), AKT3 and Phosphatidylinositol 3-kinase regulatory
subunit 2 (PIK3R2) (Table 2). Only two transcripts pertaining to
extracellular matrix-adhesion signalling cascades, COL1A2 and
PAK1, were significantly represented (P,0.05; q#0.22) in
blastocyst 3 (Table 2).
Expression of Components Involved in Purine and
Pyrimidine, Amino Acid and Carbohydrate Metabolism
Purine and pyrimidine metabolism are important for the
synthesis of new ribonucleotides during the process of meiosis,
cell division, protein synthesis and DNA repair. Components of
these pathways were significantly expressed (P,0.05; q#0.22) in
all oocyte and blastocyst samples. Adenosine monophosphate
deaminase 2 (AMPD3), Fragile histidine triad gene (FHIT),
phosphodiesterase 8B polymerase II RNA subunit E (POLR2E)
and polymerase II RNA subunit G (POLR3G) were amongst those
transcripts uniquely expressed in all oocytes. CTP synthetase
(CTPS1), inosine-5-prime-monophosphate dehydrogenase1
(IMPDH1) and phosphoribosylformyl-glycinamidine synthase
(PFAS) were uniquely expressed in all blastocyst samples. Some
components of these pathways were common to all oocyte and
blastocyst samples and include adenosine phosphoribosyltransfer-
ase (APRT), deoxyguanosine kinase (DGUOK) guanine monophos-
phate synthetase (GMPS), polymerase 1 RNA subunit B
(POLR1B), polymerase II RNA subunit L (POLR2L),primase
polypeptide 2A (PRIM2) and ribonucleotide reductase M2 B
(RRM2B) (Table 1). Oocytes 1 and 2 expressed a number of
components that were highly represented in the ribonucleotide
synthesis pathways (P,0.05; q#0.22) including adenosine deam-
inase (ADA), adenosine kinase (ADK), adenylate kinase-2 and 5
(AK2, -5) and phosphodiesterase 1B (PDE1B). In contrast, oocyte 3
did not significantly express unique components of this pathway
(Table 2), suggesting that it might have reduced developmental
competence. Blastocysts 1 and 2 also significantly expressed
adenosine deaminase (ADA), together with PDE6D, polymerase
DNA epsilon (POLE) and polymerase (RNA) III (DNA directed)
polypeptide C (POLR3C).
Components of the pyruvate metabolism pathway were
significantly expressed in oocytes and blastocysts (Table 1). Lactate
dehydrogenase A-like 6A (LDHAL6A), acylphosphatase erythro-
cyte (ACYP1) were unique to all oocyte samples whereas the
previously mentioned DLAT together with pyruvate dehydroge-
nase, beta polypeptide B (PDHB) were significantly (P,0.05;
q#0.22) expressed and found only in all blastocyst samples.
Pyruvate dehydrogenase complex, E1 alpha polypeptide 1
(PDHA1) and galactose mutarotase (GALM) expression was
common to all oocyte and blastocyst samples (Table 1). In
contrast, when comparing stage-specific differential expression of
pyruvate metabolic components within individual samples, oocytes
1 and 2 were the only samples to express one transcript
representative of the pyruvate metabolism pathway, lactate
dehydrogenase B (LDHB) (Table 2).
Our study also demonstrated significant expression (P,0.05;
q#0.22) of a number of components involved in valine, leucine
and isoleucine metabolism. Interestingly, few transcripts were
expressed in all 3/3 oocytes (Table 1). In contrast, a number of
transcripts were expressed in all 3/3 blastocyst samples (Table 1).
Only one transcript, PDHA1 was significant and common to all
oocyte and blastocyst samples (Table 1). Branched chain
aminotransferase 1 (BCAT1) and hydroxyacyl-CoA dehydroge-
nase (HADHB) were unique to oocytes 1 and 2, relative to the
third oocyte sample (Table 2). Oocyte 3 uniquely expressed acyl-
CoA dehydrogenase short/branched chain (ACADSB) and blasto-
cysts 1 and 2 expressed alcohol dehydrogenase 7 A1 (ALDH7A1)
(Table 2).
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Components of arginine, proline, glycine, serine and threonine
metabolic pathways were not detected at significant levels in all
oocyte and blastocyst samples. However, oocytes 1 and 2 did
significantly express two pathway components, delta-aminolevuli-
nate synthase 1 (ALAS1) and cystathionine beta-synthase (CBS)
and ALDH9A1 was significantly expressed in blastocysts 1 and 2.
Components of the glycolytic pathway were found to be
significantly expressed in oocytes and blastocysts (Tables 1 and 2).
LDHAL6A was unique to all oocyte samples whereas PDHB and
DLAT were unique to all blastocyst samples. LDHA and PDHA1
were significantly expressed in all oocyte and blastocyst samples
(Table 1).
Oocytes 1 and 2, but not 3 expressed a number of significantly
represented glycolytic pathway components (P,0.05; q#0.22)
(Table 2), including aldolase A fructose-bisphosphate (ALDOA),
LDHB, phosphoglycerate mutase 1 (PGAM1) and CBS. Oocyte 3
expressed one unique transcript at a significant level (P,0.05;
q#0.22), phosphoglucomutase 2 (PGM2). Blastocysts 1 and 2
uniquely expressed alcohol dehydrogenase 7 (ADH7) and
ALDH7A1 while DLAT and PGM2 were uniquely expressed by
blastocyst 3 (Table 2).
Discussion
We describe a global analysis of gene expression at stages
spanning human preimplantation development, at the level of the
individual oocytes/embryos. The variability in gene expression
which we have found between oocytes and embryos at the same
stage requires the re-interpretation of previous microarray studies
based on pooling a number of oocytes and embryos at each
developmental stage. This practice, common in studies of animal
embryos where development is relatively homogeneous, has
unfortunately obscured the heterogeneity in development which
is a hallmark of early human embryos. Understanding this is key to
understanding the molecular basis of early human development,
the establishment of developmental competence and for distin-
guishing the molecular fingerprints of viable and non viable
embryos in assisted reproduction treatments. Previous data from
pooled embryos represent averages of individual sample tran-
scripts and are likely to be highly unrepresentative of normal
development. False negative results arise since high expression of
an important gene may be an important marker of viability, but be
diluted out by lack of expression in non viable embryos, or
conversely, false positives will arise when only one individual
embryo sample of a pool provides the transcript contribution and
apparent expression of a gene in the pool.
Our approach has identified a number of molecular pathways
that are exclusive to each developmental stage or alternatively
common amongst different stages, and revealed differences in gene
expression between individual human oocytes and blastocysts. Our
approach furthermore provides a quantitative estimate of the
extent of embryonic genome activation, by comparing transcrip-
tion between developmental stages, and the extent to which this
varies between individual embryos. We identified components that
were unique to each individual sample, and we propose that some
transcripts may represent potential markers of oocyte and embryo
competence and viability. Of course expression of mRNA
transcripts does not necessarily imply translation of that gene
product to a protein product, nor does it provide information on
post translational processing or function such as enzyme activity.
These require detailed follow-up studies using assays with
sensitivity sufficient for single embryos, e.g. protein localisation
studies [23], enzyme activity studies [39], or systems biology
approaches such as metabolomics [40,41].
We identified a number of stage-specific transcripts, transcripts
detected in common between developmental stages as well as those
unique to particular samples. Oocytes, four-cell embryos and
blastocysts were all enriched in transcripts for ribosomal pathways
and protein synthesis. These transcripts represent maternal
message which may persist to the blastocyst stage, or which may
be degraded and re-expressed after EGA [1,3,42]. Only one
(uncharacterised) transcript which was not expressed in blastocysts
was common to all oocytes and four-cell embryos. In at least 2/3
oocytes and four-cell embryos, 30 transcripts were shared but not
expressed by blastocysts representing maternal message that were
not re-expressed by the embryonic genome. There were 6
transcripts shared by all four-cell and blastocyst embryos (but
not by oocytes) and 10 that were Present in at least 2/3 four-cell
and blastocysts. These transcripts represent mRNAs that are
expressed from 4-cell EGA though the preimplantation period and
include CCBE1, a tumour suppressor gene with a suggested role in
extracellular matrix remodelling and the cyclic AMP antagonist
PDE6B responsible for removing cAMP. One transcript coding for
the maternal imprinted gene MEG3 (accession number AI133721)
was also exclusively expressed in all four-cell embryos. CCBE1,
PDE6B or MEG3 have not previously been reported in human
preimplantation embryo development. Croteau et al [43] reported
one isoform of MEG3 expression in mouse oocytes and two-cell
embryos. In our data other transcripts coding for MEG3 were also
detected in 2/3 oocytes (accession number AI950273) and 1/3
blastocysts (accession number BF956762). The variable expression
of this gene emphasises the importance of using single oocytes and
embryos for analysis.
Cell Cycle Regulation and an Oocyte Signature
The importance of several components involved in apoptosis,
cell cycle and progesterone mediated oocyte maturation pathways
in the development of competent oocytes and embryos have been
reported in previous studies [22,42,44–50] and Assou et al [51]
used microarray to assess gene expression in pooled human
oocytes and human embryonic stem cells (hESCs) as a model for
early embryonic development. Assou et al [51] described a unique
oocyte signature comprising of DAZL, SOX30, AURKC and
PTTG3P, amongst other transcripts and these were significantly
expressed in oocytes in our study. Components of this signature
comprised CHEK1, FBXO5, CDK7 and CDK8. Our data showed
that CHEK1, was significantly expressed in all oocytes and
blastocysts. This kinase is postulated to inhibit CDC25C in the
event of DNA damage, thus preventing activation of the CDC2-
cyclin B complex and entry to mitosis [52]. Zhang et al [42]
assessed the gene expression profiles of human germinal vesicle
oocytes relative to hESCs and foreskin fibroblasts and identified
GDF9 and ZP2 and MOS as oocyte-specific genes highly
represented in hGVOs. These genes were also expressed at a
significant level in oocytes in our study; however, MOS was only
expressed in oocyte 3. BMP6, ZP1, ZP4 POMZP3, ZAR1, NLRP5
and FIGLA were highly represented in oocytes and down-regulated
at the blastocyst stage. With the exception of BMP6 (all blastocysts
only) and ZP1 (1/3 oocytes and all blastocysts), our study is
consistent with these findings. However our data identify
differences in expression compared to the above studies, again
emphasising the importance of analysing single embryos to avoid
the misleading averaging effect of pooled samples.
TGFb Superfamily
The TGFb superfamily signalling pathway has been implicated
in many biological and developmental processes including
folliculogenesis, oocyte maturation and early embryogenesis
Heterogeneity in Single Human Oocytes and Embryos
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[42,53–56] and differentiation of embryonic stem cells [57]. Our
study found that SMURF2, SP1, ACVR1, ACVR2 and FST were
enriched in all oocyte samples and SMAD5 was enriched in all
blastocysts. ACVR1 and FST expression have been detected in the
cumulus cells of cumulus-oocyte-complexes (COCs) from both
in vitro and in vivo matured oocytes [58]. Vandevoort et al [58] and
Lee et al [53] have shown a direct link between the levels of FST
and oocyte competence in terms of increased blastocyst formation
rate, increased total blastocyst cell number and increased total
trophoblast cell number. Components of the TGFb signalling
cascade were enriched in oocytes 1 and 2 and blastocysts 1 and 2.
In light of the known importance the TGFb cascade in oocyte
competence and early embryogenesis (reviewed in [54]) the
expression of these molecules in these samples relative to oocyte
3 and blastocyst 3 may be an important indicator of their
developmental competence.
Adhesion Receptors and the Extracellular Matrix (ECM)
Extracellular matrix molecules are important in the formation
of a fully differentiated, implantation competent blastocyst [59,60].
Adhesion proteins also have important roles in the maintenance of
pluripotency and ES cell differentiation [61] D. Soteriou, D.
Brison, SJ Kimber in prep). In common with previous studies, we
have identified a number of constitutively expressed and stage
specific adhesion receptors and ECM molecules. Integrin b1
(ITAB1) was expressed in all oocytes and all blastocysts whereas
ITAB3 was exclusive to all blastocysts. However, transcripts for the
binding partner to ITAB3, av integrin (ITAV) were only detected
in blastocyst 2 and oocytes 2 and 3. Since ITAB3 is detected only
post 4-cell, it is likely the ITAV protein in oocytes binds to an
alternative partner, possibly ITAB5, which was expressed in all
oocytes and blastocysts. Integrin avb5 binds to fibronectin (as well
as other apparently non expressed molecules e.g. vitronectin), and
we found FN1 expressed at significant levels in all oocytes and one
transcript representative of FN1 (accession number W73431) was
detected in blastocysts 2 and 3 but this was not significant. Integrin
avb3 binds to laminin and LAMB1 and LAMB5 were common to
all oocytes and blastocysts. It has been postulated that ECM
molecules may act as bridging proteins to bring the TE to the
luminal surface of the uterus for implantation [23,62]. However,
FN1 and LAMB1 null murine embryos still implant, although
LAMB1 null embryos die after implantation due to failure of
endoderm differentiation [63,64].
Metabolic Pathways
Previous reports have investigated the metabolic profile of
oocytes and preimplantation embryos as a non-invasive method to
identify competent oocytes and viable embryos with a view to
utilising this in assisted reproductive technologies [65–71].
Pyruvate, synthesised via the metabolism of glucose, and glucose
itself, are the major sources of energy for preimplantation
development and mature oocytes [72 73]. The culture of oocytes
in sub-optimum glucose conditions have been suggested to result
in failure of resumption and completion of meiosis, a decrease in
cytoplasmic maturation and reduced developmental potential [74–
76]. Moreover, glycolysis results in the production of pyruvate and
phosphoribosylpyrophosphate, the latter forms the substrate for de
novo purine synthesis [73]. Our study found components of the
glucose metabolism pathway in all oocytes and blastocysts.
However, components were also significantly represented in each
sample. Oocytes 1 and 2 expressed a different cohort of glucose
metabolism components than oocyte 3. A similar pattern was
observed for blastocysts 1 and 2 relative to 3. Although different
transcripts of the glucose metabolism pathway were enriched in
each sample, it is unknown whether expression of different genes
was indicative of oocyte or blastocyst viability.
Amino acid turnover by preimplantation embryos is related to
embryo developmental competence and clinical outcome in ART
[68 69]. Houghton et al [68] related amino acid profile to
blastocyst formation and showed that during embryo culture, Leu
was continuously depleted from the media and Glu and Ala was
synthesised by embryos on day 2/3 that went on to reach the
blastocyst stage. After day 3, Leu depletion was accompanied by
Arg, Ser, Met and Val depletion in embryos that reached
blastocyst stage. Brison et al reported a significant depletion of
Leu and Ser from the media indicative of embryos that will give
rise to pregnancy. In contrast to Houghton et al, this profile was
accompanied by a decrease in Gly and increases in Asn and Arg
[68,69]. We found components of the Leu metabolism pathway
significantly enriched in oocytes and blastocysts. Components of
Ser metabolism were also expressed in oocytes 1 and 2 suggesting
again that these are competent relative to oocyte 3. Interestingly,
no components in the Ser metabolic pathway were significantly
expressed in blastocysts, suggesting that this viability is conferred
by inheritance of maternal message.
Materials and Methods
Embryos
Human oocytes and embryos were donated to research after
fully informed patient consent in writing, with approval from
Central Manchester Research Ethics Committee and the Human
Fertility and Embryology Authority (research licence R0026).
Fresh oocytes and embryos surplus to IVF requirement were
obtained from Saint Mary’s Hospital, Manchester. Basal charac-
teristics of the patients donating embryos are as detailed in Roberts
et al. [77]. For ethical reasons it was only possible to obtain failed
to fertilise oocytes for analysis. Failed to fertilise oocytes were
obtained 24h after insemination and after removing any contam-
inating cumulus cells the oocytes were lysed immediately for
polyAPCR amplification as previously described [26,27]. All
embryos were surplus to infertility treatment and developmentally
scored, according to standard clinical grading systems used at St
Mary’s Hospital [78]. All embryos scored $3 for equal blastomere
size and $3 for level of fragmentation and their speed of
development was normal. Early cleavage embryos were obtained
at the two-four cell stage on day 2 of development and cultured to
the four- and eight-cell stage in 50 ml drops of G1 medium
(Vitrolife, UK) overlaid by liquid paraffin (Medicult UK Ltd, UK).
Embryos at the eight-cell stage were transferred to 50 ml drops of
G2 medium (Vitrolife, UK) overlaid with liquid paraffin and
cultured from the eight-cell stage to the blastocyst stage.
Blastocysts were graded using the Gardner and Schoolcraft
method [79] and only blastocysts with the minimum grade of
5BB were used.
Embryo Lysis, Reverse Transcription, Global Amplification
(PolyAPCR) and Hybridisation to Human Genome U133
Plus 2.0 Arrays
Oocytes and embryos were lysed and reverse transcribed as
previously described [23,27]. PolyAPCR was performed to amplify
mRNA, as described by Brady and Iscove [26]. This procedure
amplifies all polyadenylated RNA in a given sample. The cDNA
collection thus produced preserves the relative abundance of the
mRNAs present in the original sample [80–82]. PolyAcDNA was
then subjected to a second round of amplification and biotin-16-
dUTP labelling using EpiStem’s proprietary PolyAPCR based
systems, EpiAmpTM (PolyAPCR based amplification) and EpiLa-
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belTM (PolyA-PCR labelling), according to the Manufacturer’s
instructions. All samples were assayed for expression of b-actin as
the expression of this gene was our minimum inclusion criteria for
microarray analysis. Labelled PolyAcRNA was hybridised to
Affymetrix Human Genome U133 Plus 2.0 arrays.
Analysis and Normalisation of Gene Expression Data
Gene expression analysis and normalisation MAS 5.0 method
(Affymetrix. Affymetrix Microarray Suite User Guide. Affymetrix,
Santa Clara, CA, version 5 edition, 2001) were performed using
Bioconductor [83]. Differential expression analysis was performed
using Limma using the functions lmFit and eBayes [84]. Genelists
of differentially expressed genes were controlled for false discovery
rate (fdr) errors using the method of QVALUE [85]. Hierarchical
clustering was performed on a subset of 10,432 probesets that were
Present in at least 2/3 samples of oocyte or blastocyst using Partek
Genomics Solution (version 6.3, Copyright 2005, Partek Inc., St.
Charles, MO, USA). We deliberately set the threshold for calling a
gene present on the array conservatively, in order to minimise the
rate of false negative data. As a result of this of course, low level
expression of some genes may be not called present. Clustering
was performed on gene expression values of each sample group
(log 2) that had been z-transformed (for each probeset the mean set
to zero, standard deviation to 1).’’ All microarray data is MIAME
compliant and has been deposited with EMBL-EBI (accessed at
http://www.ebi.ac.uk; accession number E-MEXP-3870).
Analysis and interpretation of the data was performed using the
functional annotation tool of the Database for Annotation,
Visualization and Integrated Discovery (DAVID) 2.1 programme
[86].
Summary
Analysis of individual oocytes, four-cell embryos and blastocysts
has given us insight into the molecular signature underpinning
human preimplantation development. Our study has highlighted
the importance of using single oocytes and embryos in order to
understand the heterogeneity inherent in human development,
and to identify potential markers or pathways indicative of
competence and viability. The substantial differences in transcript
number in each categories of the Venn diagrams (Figure 4)
between the 3/3 data and the 2/3 data illustrates the magnitude of
the variation between morphologically similar oocytes/embryos at
each stage. Previously published microarray data using pooled
samples of oocytes/embryos may have skewed the data and
masked these differences. Although a number of pathways were
represented in our microarray readout, we found more compo-
nents representative of cell cycle regulation, adhesion receptor/
ECM and regulation of purine, pyrimidine and amino acid
metabolism in oocytes 1 and 2 than oocyte 3. These results may
suggest that oocyte 3 had reduced developmental competence.
However our previous research on the chemical activation of
failed to fertilise oocytes demonstrates some of these oocytes can
generate blastocysts and embryonic stem cell lines [29,30,87].
Similarly, blastocysts 1 and 2 expressed more components of these
pathways than blastocyst 3 again suggesting some compromise in
the latter, especially as some of these components are required for
TE differentiation and extracellular matrix modelling, which are
required for successful implantation and amino acid metabolism,
an important marker of embryo viability. Our data provides
additional information on the temporal and differential gene
expression profile of individual human oocytes and preimplanta-
tion embryos and can be utilised as a basis for further investigation
to aid identification of viable embryos for transfer in ART, the
health of ART children and understanding the basis of pluripo-
tency in stem cell lines.
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